This observational study evaluated the long-term safety and efficacy of clomiphene citrate (CC) for managing hypogonadism in men. The study followed 46 men (mean age 44) with baseline testosterone levels averaging 228 ng/dL, showing significant increases to 612 ng/dL at 1 year, 562 ng/dL at 2 years, and 582 ng/dL
